CLINICAL_TRIALS
trial_result
· 2022-05-18
Clinical Trial Update: Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease [Phase 4]
Summary
Phase 4 clinical trial investigating nighttime agitation and restless legs syndrome in people with Alzheimer's disease is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas at Austin | Conditions: Alzheimer Disease | Phase 4 | Status: RECRUITING